Hirai T, Mori Y, Ogura T, Kondo Y, Sakazaki Y, Ishitsuka Y
J Pharm Health Care Sci. 2024; 10(1):60.
PMID: 39334301
PMC: 11437979.
DOI: 10.1186/s40780-024-00380-8.
Jia L, Hu Y, Jin G
Medicine (Baltimore). 2024; 103(37):e39649.
PMID: 39287282
PMC: 11404871.
DOI: 10.1097/MD.0000000000039649.
Tayal R, Yasmin S, Chauhan S, Singh T, Saini M, Shorog E
Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895858
PMC: 10609986.
DOI: 10.3390/ph16101387.
Kiecka A, Szczepanik M
Pharmacol Rep. 2023; 75(4):791-804.
PMID: 37142877
PMC: 10159235.
DOI: 10.1007/s43440-023-00489-x.
Losurdo G, Caccavo N, Indellicati G, Celiberto F, Ierardi E, Barone M
J Clin Med. 2023; 12(8).
PMID: 37109245
PMC: 10146626.
DOI: 10.3390/jcm12082910.
Anastomotic stricture prediction in patients with esophageal atresia with distal fistula.
Newland N, Snajdauf J, Kokesova A, Styblova J, Hradsky O, Meusel I
Pediatr Surg Int. 2023; 39(1):136.
PMID: 36811679
PMC: 9947071.
DOI: 10.1007/s00383-023-05423-z.
Gastroesophageal reflux disease and oral symptoms: A two-sample Mendelian randomization study.
Jiang S, Zheng L, Miao Z
Front Genet. 2023; 13:1061550.
PMID: 36685839
PMC: 9845290.
DOI: 10.3389/fgene.2022.1061550.
Bone microstructure in proton pump inhibitor users.
Kondapalli A, Agarwal S, Germosen C, Bucovsky M, Colon I, Kil N
Bone. 2023; 168:116668.
PMID: 36621542
PMC: 9911371.
DOI: 10.1016/j.bone.2022.116668.
A survey on the incidence of common musculoskeletal side effects among the patients taking long-term anti-ulcerant therapies in Bangladesh.
Mitra S, Hussain M, Rahman R, Salam M, Mazumder T, Farzana S
Toxicol Rep. 2022; 9:1796-1805.
PMID: 36518456
PMC: 9742954.
DOI: 10.1016/j.toxrep.2022.09.007.
Strategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial.
Hojo M, Asaoka D, Shimada Y, Nojiri S, Nagahara A
BMC Gastroenterol. 2022; 22(1):21.
PMID: 35033011
PMC: 8760744.
DOI: 10.1186/s12876-021-02086-9.
Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies.
Li J, Xie X, Liu W, Gu F, Zhang K, Su Z
Front Pharmacol. 2021; 12:712939.
PMID: 34421609
PMC: 8378906.
DOI: 10.3389/fphar.2021.712939.
Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro.
Staines K, Myers K, Little K, Ralston S, Farquharson C
Calcif Tissue Int. 2021; 109(6):696-705.
PMID: 34213594
PMC: 8531085.
DOI: 10.1007/s00223-021-00882-9.
Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis.
Kanbayashi Y, Sakaguchi K, Hongo F, Ishikawa T, Tabuchi Y, Ukimura O
Sci Rep. 2021; 11(1):978.
PMID: 33441770
PMC: 7806964.
DOI: 10.1038/s41598-020-80243-y.
Evidence-based application of explicit criteria to assess the appropriateness of geriatric prescriptions at admission and hospital stay.
Di Martino E, Provenzani A, Polidori P
PLoS One. 2020; 15(8):e0238064.
PMID: 32841285
PMC: 7446960.
DOI: 10.1371/journal.pone.0238064.
Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
Hojo M, Asahara T, Nagahara A, Takeda T, Matsumoto K, Ueyama H
Dig Dis Sci. 2018; 63(11):2940-2949.
PMID: 29796911
PMC: 6182435.
DOI: 10.1007/s10620-018-5122-4.
Intestinal calcium and bile salts facilitate germination of Clostridium difficile spores.
Kochan T, Somers M, Kaiser A, Shoshiev M, Hagan A, Hastie J
PLoS Pathog. 2017; 13(7):e1006443.
PMID: 28704538
PMC: 5509370.
DOI: 10.1371/journal.ppat.1006443.
Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.
Fisher L, Fisher A
Clin Drug Investig. 2017; 37(7):587-624.
PMID: 28361440
DOI: 10.1007/s40261-017-0519-y.
Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?.
Safe M, Chan W, Leach S, Sutton L, Lui K, Krishnan U
World J Gastrointest Pharmacol Ther. 2016; 7(4):531-539.
PMID: 27867686
PMC: 5095572.
DOI: 10.4292/wjgpt.v7.i4.531.
Acid-suppressive medications and risk of fracture: an updated meta-analysis.
Cai D, Feng W, Jiang Q
Int J Clin Exp Med. 2015; 8(6):8893-904.
PMID: 26309543
PMC: 4538134.
Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
Zhang Y, Li Q, He B, Liu R, Li Z
World J Gastroenterol. 2015; 21(20):6341-51.
PMID: 26034370
PMC: 4445112.
DOI: 10.3748/wjg.v21.i20.6341.